DISCOVER
MOLECULAR
INTERACTIONS

Binding Kinetics  I  Conformational Changes

LEARN MORE

switchSENSE®  – Comprehensive biophysical information,
in one measurement.

LEARN MORE

Affinity, dose responseKD, IC50, fM sensitivityProtein diameterDH, ΔDH = 0.1 nm
KineticskON, kOFFThermodynamics ΔH, ΔS, ΔG
Avidity, bispecificsTwo-color detectionNucleic acid enzyme activitykCAT, KM, kEXO
Conformational changes% friction change
folding/unfolding
agglomeration
  

 

switchSENSE®

Products

made for high-performance analysis.

heliX® Biosensors

heliX® pushes the boundaries of what has been possible in biosensing to help you do more. 

Adapter Biochip

​One chip. One workflow.
Many ways to functionalize
the surface. 

Reagents & Consumables

Coupling & capture kits, starter packs, tutorial & test kits, buffers, solutions and other consumables.

proFIRE® Conjugation

Your effortless workflow to well-defined protein-DNA conjugates. 

In focus

Browse through the latest publications.

Paper in Nature Communications I 18 June 2021

Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action

Congratulations to Florian Kast and our collaborators from Andreas Plückthun´s group at the University of Zurich for this impressive Nature Communications paper.

The paper shows that an engineered anti-Her2 tetravalent antibody construct that binds to two different Her2 epitopes (biparatopic) significantly increases the anti-tumoral efficacy over trastuzumab or pertuzumab treatments. The biparatopic tetravalent antibody induces cluster formation of Her2 molecules on the cancer cell surface by its crosslinking capabilities leading to enhanced Her2 growth factor receptor internalization and degradation.

Besides determination of precise binding kinetics of all constructs, the superior distance-dependent crosslinking capabilities of the tetravalent construct over its parental antibody constructs at different Her2 surface densities were measured and quantified by the switchSENSE® technology. A dynamicBIOSENSORS’ internal simulation algorithm confirmed the measured crosslinking effects at different Her2 densities.

READ MORE

Paper in PNAS I 30 March 2021

CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS

Our collaborators at Scripps Research Institute used the switchSENSE® technology in this paper to analyze the different conformations of the wild-type and mutant versions of the alanyl-tRNA synthetase protein (AlaRS).

The switchSENSE® conformation analysis robustly detected four mutations in AlaRS leading to up to 12% size increase over the wild-type as major drivers of tRNA synthetase expansion. These results were confirmed by further independent biophysical analyses (small-angle X-ray scattering and hydrogendeuterium exchange). Interestingly, an expansion of the protein by mutations in the aminoacylation domain was shown to correlate with increased neuropilin 1 (Nrp 1) binding capabilities and disease severity of the Charcot-Marie-Tooth disease, a neurological disorder.

With this finding, the conformation analysis helped to understand the connection between AlaRS expansion and Nrp binding, thus providing more insights to potentially cure this inherited disorder.

READ MORE

Paper in Environmental Toxicology and Pharmacology I November 2020

Affinity of chlordecone and chlordecol for human aerum lipoproteins

Chlordecone (CLD) is a chlorinated persistent organic pollutant (POP) whose presence despite the 1993 ban in agriculture areas has caused numerous public health concerns. CLD accumulates in the liver, and the CLD metabolite, chlordecol (CLD-OH) is found in bile, an important site of excretion for cholesterol transported to the liver via lipoproteins.

Here, we studied the real-time molecular interaction between CLD and CLD-OH with human serum lipoproteins, LDL and HDL. While no interaction was detected between CLD and HDL, or between CLD-OH and LDL, relatively high specific affinities were observed between CLD and CLD-OH for LDL and HDL, respectively.

READ MORE

→ click here for a list of all switchSENSE® publications.